The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.
I'm A Celebrity fans have sparked a major debate over which of the final three stars deserves to win. Read more.
TOKYO -- Japanese researchers from Keio University and elsewhere announced Thursday that they have begun a clinical trial on a gene therapy to restore light sensitivity in patients with retinitis ...
Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...
2d
Hosted on MSNJones Trading Initiates Coverage of ProQR Therapeutics N.V. (PRQR) with Buy RecommendationFintel reports that on February 12, 2025, Jones Trading initiated coverage of ProQR Therapeutics N.V. (NasdaqCM:PRQR) with a ...
The 47-year-old comedian - who lost his sight when he was 22 due to hereditary condition Retinitis Pigmentosa - became the ...
In February, the Tulsa World is sharing a series of thoughts from Black Tulsans about the future of Tulsa and what role they are playing to make it happen.
Chris feels contestants need to be "tough" in order to survive the stresses of 'Strictly'. The comedy star is blind due to ...
The comedian, who became the first blind person to win Strictly Come Dancing in 2024, opened up about the 'shame' he felt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results